Clade TX

Cambridge, United States Founded: 2020 • Age: 6 yrs Acquired By Century Therapeutics
Stem cell-derived therapies for cancer are developed using pluripotent cells.
Request Access

About Clade TX

Clade TX is a company based in Cambridge (United States) founded in 2020 by Leandro Vetcher was acquired by Century Therapeutics in April 2024.. Clade TX has raised $87 million across 1 funding round from investors including Century Therapeutics, Syncona and Bristol-Myers Squibb. The company has 13 employees as of December 31, 2021. Clade TX has completed 1 acquisition, including Gadeta. Clade TX operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.

  • Headquarter Cambridge, United States
  • Employees 13 as on 31 Dec, 2021
  • Founders Leandro Vetcher
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Clade Therapeutics, Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $87 M (USD)

    in 1 rounds

  • Latest Funding Round
    $87 M (USD), Series A

    Nov 03, 2021

  • Investors
  • Employee Count
    13

    as on Dec 31, 2021

  • Investments & Acquisitions
  • Acquired by
    Century Therapeutics

    (Apr 12, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Clade TX
Headcount 10-50
Employee Profiles 5
Board Members and Advisors 9
Employee Profiles
People
Chad Cowan
CEO & Co-Founder
People
Melissa Chin
Principal Research Associate
People
Grant Welstead
Executive Director, Disease Biology
People
Kristen Dettloff
Senior Research Associate, Cell Differentiation

Unlock access to complete

Funding Insights of Clade TX

Clade TX has successfully raised a total of $87M through 1 strategic funding round. The most recent funding activity was a Series A round of $87 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $87.0M
  • First Round

    (03 Nov 2021)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2021 Amount Series A - Clade TX Valuation Syncona
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Clade TX

Clade TX has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Century Therapeutics, Syncona and Bristol-Myers Squibb. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Healthcare investments are managed via private equity by Syncona.
Founded Year Domain Location
Healthcare startups are funded by this corporate-backed venture capital entity.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Clade TX

Clade TX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Gadeta. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
T Cell based cancer therapies based on gamma delta (γδ) T cell receptors
2015
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Clade TX

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Clade Tx Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Clade TX

Clade TX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
mRNA-based therapeutics for diseases including cancer and infections are developed.
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Targeted and immune-oncology drugs for cancer treatment are developed.
domain founded_year HQ Location
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
domain founded_year HQ Location
Small molecules are developed for cancer and skin disease treatments.
domain founded_year HQ Location
Cancer therapies are developed using selective pathway inhibitors.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Clade TX

When was Clade TX founded?

Clade TX was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Where is Clade TX located?

Clade TX is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Is Clade TX a funded company?

Clade TX is a funded company, having raised a total of $87M across 1 funding round to date. The company's 1st funding round was a Series A of $87M, raised on Nov 03, 2021.

How many employees does Clade TX have?

As of Dec 31, 2021, the latest employee count at Clade TX is 13.

What does Clade TX do?

Clade was founded in 2020 and is based in Cambridge, United States. Platform technologies are utilized by the company to create therapies derived from human pluripotent stem cells and their derivatives. These therapies focus on cell transplantation for cancer treatment within the biotechnology sector. Operations emphasize the advancement of stem cell-based solutions for oncology applications.

Who are the top competitors of Clade TX?

Clade TX's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.

How many acquisitions has Clade TX made?

Clade TX has made 1 acquisition, including Gadeta.

Who are Clade TX's investors?

Clade TX has 5 investors. Key investors include Century Therapeutics, Syncona, Bristol-Myers Squibb, LifeSci Venture Partners, and Emerson Collective.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available